Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Explore how to use your unique talents to create additional income streams. Start generating extra cash for debt repayment.
19,470 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Vanguard’s VTSAX has posted roughly a 300% gain over the last ten years, outpacing most active funds amid a tech-driv...
Prices rose again in April as energy costs jumped, keeping inflation on households' radar. The latest CPI data show b...
A leading model places a solvency ceiling around 210% of GDP, a level that could push policymakers toward sweeping re...
A landmark massive multi-billion-dollar industry merger is reshaping how investors view McCormick, nudging it from a ...
BlackRock indicates bitcoin’s portfolio role is evolving toward a small, strategic allocation as more institutions se...
New Jersey moves to charge employers with Medicaid beneficiaries, aiming to fund the joint state-federal program amid...
A fresh look at retirement saving shows the typical worker saves far less than the official 401(k) limit, creating a ...
Rising housing costs are reshaping life plans as couples delay marriage to save for a home. The market for first-time...
Trip.com Group delivered a strong Q4, with revenue up 21% and international growth outpacing domestic momentum. The q...
Universal Corp misses EPS and swings to a loss in the third quarter, triggering a double-digit stock drop. Analysts f...
Joe Kent, a former Army Special Forces officer and two-time congressional candidate, quit today from a top counterter...